ISPOR Announces Appointment of New Associate Chief Science Officer

Published Jan 22, 2018
Lucinda Strycker Orsini Joins the Society in New Science Role   Lawrenceville, NJ, USA—January 22, 2018—ISPOR, the professional society for health economics and outcomes research, announced today that Lucinda Strycker Orsini, DPM, MPH has joined the Society’s leadership team in the role of Associate Chief Science Officer. In this new role, Dr. Orsini will work closely with ISPOR’s Chief Science Officer, Richard J. Willke, PhD to direct, lead, and execute strategic initiatives related to research, scientific, and content priorities to advance the Society’s mission to promote health economics and outcomes research excellence to improve decision making for health globally. Dr. Orsini brings significant experience in the field of health economics and outcomes research (HEOR) to her new role at ISPOR. Her most recent position was as Vice President at Parexel where she led an HEOR team that provided a wide range of consulting services. Previously, Dr. Orsini worked at Bristol-Myers Squibb since 2005 where she held a variety of positions with increasing responsibility. Her most recent position at Bristol-Myers Squibb was Group Director in the worldwide HEOR group supporting oncology/immuno-oncology products. Previous to this, she was at Thomson Medstat where she worked extensively with real-world data studies. Dr. Orsini has her Doctor of Podiatric Medicine from Temple University, Master of Public Health from the Harvard T.H. Chan School of Public Health, and Bachelor of Science from Cornell University. “We are very excited to announce the appointment of Lucinda Orsini into the new role of Associate Chief Science Officer,” stated ISPOR’s Chief Science Officer Richard J. Willke, PhD. “Lucinda brings a wealth of experience in HEOR to her new role and will help advance the many strategic initiatives at the Society.”

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg    

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×